Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence
Diseases · 10.05.2026 · 14 (5) · 167
DOI: 10.3390/diseases14050167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 10.05.2026. Verfasst von Lavinia-Alexandra Moroianu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, Dunarea de Jos University of Galați, 800008 Galati, Romania. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Evidence linking vitamins D and B12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats.
Methods
We conducted a PRISMA 2020 systematic review and exploratory meta-analysis of nutrient-specific status and supplementation evidence. PubMed/MEDLINE, APA PsycInfo, Cochrane Library, Google Scholar, ClinicalTrials.gov, and ProQuest were searched for human studies published in 2016–2025, with a final update on 1 March 2026. Forty-six studies were included (24 randomized controlled trials, 22 observational studies; N = 69,902), and 44 contributed quantitative data. Effects were harmonized to odds ratios (ORs) for cross-family comparability and pooled using Hartung–Knapp random-effects models; supplementation evidence was additionally interpreted on the standardized mean difference (SMD) scale.
Results
Across the main evidence families, pooled estimates showed substantial heterogeneity and limited generalizability. Vitamin D supplementation showed an initial inverse estimate on the secondary harmonized OR scale (OR = 0.439, 95% CI 0.272–0.710) and a clinically interpretable SMD of −0.454 (95% CI −0.718 to −0.189), but heterogeneity was high (I2 = 84.2%) and trim-and-fill attenuated the OR estimate to the null (OR = 0.88, 95% CI 0.48–1.63). Vitamin D status showed a similar pattern (primary OR = 0.615, 95% CI 0.424–0.890; trim-and-fill OR = 0.90, 95% CI 0.54–1.49). Vitamin B12 status was inversely associated with outcomes (OR = 0.310, 95% CI 0.115–0.834), but heterogeneity was extreme (I2 = 94.8%). B12 supplementation evidence was sparse and null.
Conclusions
The evidence supports targeted deficiency assessment, not routine supplementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, Dunarea de Jos University of Galați, 800008 Galati, Romania.
- Faculty of Medicine, "Ovidius" University of Constanta, Mamaia Boulevard 124, 900527 Constanta, Romania.
ORCID-Profile: Lavinia-Alexandra Moroianu, Valeriu Ardeleanu, Alina Pleșea-Condratovici
Zitieren
APA
Moroianu, L. A., Curis, C., Ardeleanu, V., Bogdan-Goroftei, R. E., Mitincu-Caramfil, S. D., Moroianu, M., & Pleșea-Condratovici, A. (2026). Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence. Diseases, 14(5), 167. https://doi.org/10.3390/diseases14050167
Vancouver
Moroianu LA, Curis C, Ardeleanu V, Bogdan-Goroftei RE, Mitincu-Caramfil SD, Moroianu M, et al. Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence. Diseases. 2026;14(5):167. doi:10.3390/diseases14050167
BibTeX
@article{Moroianu2026,
author = {Moroianu, Lavinia-Alexandra and Curis, Cecilia and Ardeleanu, Valeriu and Bogdan-Goroftei, Roxana Elena and Mitincu-Caramfil, Simona-Dana and Moroianu, Marius and Pleșea-Condratovici, Alina},
title = {Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence},
journal = {Diseases},
year = {2026},
volume = {14},
number = {5},
pages = {167},
doi = {10.3390/diseases14050167}
}
EUVIMED